NRx Pharmaceuticals, Inc.
NRXP
$3.28
$0.072.18%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 7.80M | 7.18M | 2.91M | 5.55M | 1.44M |
| Total Receivables | 161.00K | 3.33M | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 590.00K | 1.44M | 919.00K | 1.02M | 1.04M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 344.00K | -- | 761.00K | 693.00K | 824.00K |
| Total Current Assets | 8.89M | 11.95M | 4.59M | 7.26M | 3.30M |
|
|
|||||
| Total Current Assets | 8.89M | 11.95M | 4.59M | 7.26M | 3.30M |
| Net Property, Plant & Equipment | 696.00K | 419.00K | 8.00K | -- | 10.00K |
| Long-term Investments | 1.79M | 610.00K | -- | -- | -- |
| Goodwill | 1.79M | 610.00K | -- | -- | -- |
| Total Other Intangibles | 925.00K | 1.78M | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 253.00K | 243.00K | 240.00K | 334.00K | 339.00K |
| Total Assets | 12.96M | 15.00M | 4.84M | 7.59M | 3.65M |
|
|
|||||
| Total Accounts Payable | 4.27M | 4.26M | 3.63M | 4.31M | 4.13M |
| Total Accrued Expenses | 6.18M | 5.47M | 5.99M | 5.48M | 6.13M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 316.00K | 10.10M | 9.85M | 8.40M | 1.25M |
| Total Finance Division Other Current Liabilities | 17.81M | 20.77M | 20.98M | 14.57M | 10.35M |
| Total Other Current Liabilities | 17.81M | 20.77M | 20.98M | 14.57M | 10.35M |
| Total Current Liabilities | 28.58M | 40.59M | 40.45M | 32.75M | 21.86M |
|
|
|||||
| Total Current Liabilities | 28.58M | 40.59M | 40.45M | 32.75M | 21.86M |
| Long-Term Debt | -- | -- | -- | -- | 5.01M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 315.00K | 158.00K | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 28.89M | 40.75M | 40.45M | 32.75M | 26.87M |
|
|
|||||
| Common Stock & APIC | 290.96M | 281.50M | 265.75M | 258.62M | 255.05M |
| Retained Earnings | -306.90M | -307.26M | -301.37M | -283.79M | -278.27M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -15.94M | -25.76M | -35.62M | -25.16M | -23.22M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -15.94M | -25.76M | -35.62M | -25.16M | -23.22M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -15.94M | -25.76M | -35.62M | -25.16M | -23.22M |
|
|
|||||